Xu, K., Antonopoulos, A., Spanoudakis, E., Parry, S., Chaidos, A., Hu, M., Butters, T., Dell, A., Rahemtulla, A., Horwood, N., & Karadimitris, A. (2016). Glucose Ceramide Synthase Inhibitors Inhibit Osteoclast Activation Induced by Myeloma-Derived and De Novo Synthesized Glycosphingolipids. 114(22), 176–176.

Xu, K., et al. Glucose Ceramide Synthase Inhibitors Inhibit Osteoclast Activation Induced by Myeloma-Derived and De Novo Synthesized Glycosphingolipids. no. 22, 2016, pp. 176–76.

Xu, K, A Antonopoulos, E Spanoudakis, S Parry, A Chaidos, M Hu, T Butters, et al. 2016. “Glucose Ceramide Synthase Inhibitors Inhibit Osteoclast Activation Induced by Myeloma-Derived and De Novo Synthesized Glycosphingolipids.” In , 114:176–76.